EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Tongxinluo for the Secondary Prevention of Atherosclerotic Disease: A Systematic Review and Meta‐Analysis of Randomized Clinical Trials

Yanyan Feng, Zhaobo Shi, Jiewen Zhang, Jiejie Li

Brain and Behavior · 2026-03 · 16 (3)

DOI: 10.1002/brb3.71232 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Brain and Behavior, online erschienen am 12.03.2026. Verfasst von Yanyan Feng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The People's Hospital of Zhengzhou University & Henan Provincial People's Hospital, Zhengzhou, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Atherosclerosis, Secondary Prevention. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardio‐cerebrovascular events continue to pose major life‐threatening risks worldwide. Though approved for treatment of angina pectoris and ischemic stroke, the effects of tongxinluo, as a traditional Chinese medicine, on stroke and major adverse cardiovascular events (MACE) after atherosclerotic cardiovascular disease (ASCVD) remain controversial.

Objective

This study aims to assess the efficacy of tongxinluo in the secondary prevention of ASCVD.

Methods

The present systematic review was conducted following PRISMA guidelines and the Cochrane Handbook for Systematic Reviews of Interventions . In this study‐level meta‐analysis, we conducted a comprehensive search of medical libraries and clinical trial registries, spanning from their inception until November 20, 2024, and randomized controlled trials (RCTs) comparing tongxinluo versus no tongxinluo in a secondary prevention. The ASCVD population was included. The primary outcome was stroke and MACE. The secondary outcome was MACE and myocardial infarction. Results and conclusion Four RCTs, including 7087 patients with known coronary artery disease, ischemic stroke, or carotid artery plaque, were included in the analysis. Compared to placebo, tongxinluo numerically decreased the risk of stroke with a RR of 0.84 (95% CI: 0.61–1.17, p = 0.31). For the outcome of MACE, tongxinluo reduced the risk by 28% (RR: 0.72, 95% CI: 0.59–0.88, p = 0.001). Patients randomized to tongxinluo had a RR of 0.70 (95% CI: 0.54–0.92, p = 0.01) for cardiovascular mortality and 0.74 (95% CI: 0.56–0.92, p = 0.01) for all‐cause mortality. In summary, in patients with ASCVD, tongxinluo tended to decrease the incidence of stroke, and reduced the composite of stroke, myocardial infarction, and cardiovascular mortality by 28%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalAtherosclerosisSecondary PreventionHumansRandomized Controlled Trials as TopicStrokeMyocardial Infarction

Stichwörter der Autor:innen

ASCVDMACEstroketongxinluo

Substanzen

tongxinluoDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Neurology, The People's Hospital of Zhengzhou University & Henan Provincial People's Hospital, Zhengzhou, China.
  • Department of Neurology, Kaifeng Central Hospital, Kaifeng, China.
  • Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Zitieren

APA

Feng, Y., Shi, Z., Zhang, J., & Li, J. (2026). Tongxinluo for the Secondary Prevention of Atherosclerotic Disease: A Systematic Review and Meta‐Analysis of Randomized Clinical Trials. Brain and Behavior, 16(3). https://doi.org/10.1002/brb3.71232

Vancouver

Feng Y, Shi Z, Zhang J, Li J. Tongxinluo for the Secondary Prevention of Atherosclerotic Disease: A Systematic Review and Meta‐Analysis of Randomized Clinical Trials. Brain and Behavior. 2026;16(3). doi:10.1002/brb3.71232

BibTeX
@article{Feng2026,
  author = {Feng, Yanyan and Shi, Zhaobo and Zhang, Jiewen and Li, Jiejie},
  title = {Tongxinluo for the Secondary Prevention of Atherosclerotic Disease: A Systematic Review and Meta‐Analysis of Randomized Clinical Trials},
  journal = {Brain and Behavior},
  year = {2026},
  volume = {16},
  number = {3},
  doi = {10.1002/brb3.71232}
}
Kostenlos starten →